3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9 daahirnimo ≥99.0% (HPLC) Favipiravir Dhexdhexaad COVID-19
Sahayda Ganacsi ee Favipiravir iyo Dhexdhexaadiyayaasha la xidhiidha:
Favipiravir CAS 259793-96-9
2-Aminopropanediamide CAS 62009-47-6
Diethyl Aminomalonate Hydrochloride CAS 13433-00-6
3,6-Dichloropyrazine-2-Carbonitrile CAS 356783-16-9
3,6-Difluoropyrazine-2-Carbonitrile CAS 356783-28-3
6-Fluoro-3-Hydroxypyrazine-2-Carbonitrile CAS 356783-31-8
6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9
3-Hydroxypyrazine-2-Carboxamide CAS 55321-99-8
Magaca Kiimikada | 3,6-Dichloropyrazine-2-Carbonitrile |
La mid ah | 3,6-Dichloro-2-Pyrazinecarbonitrile;Favipiravir wasakh 18 |
Lambarka CAS | 356783-16-9 |
Lambarka CAT | RF-PI226 |
Heerka Saamiyada | Kaydka dhexdiisa, Qiyaasta Waxsoosaarka Ilaa Tan |
Qaanuunka molecular | C5HCl2N3 |
Miisaanka Molecular | 173.99 |
Summada | Kiimikada Ruifu |
Shayga | Tilmaamaha |
Muuqashada | Jaalle cirro leh iyo budo caddaan ah |
Aqoonsiga HPLC | Waqtiga haynta ee ugu sarreysa sida waafaqsan heerka tixraaca |
Qoyaanka (KF) | ≤1.0% |
Hadhaaga dabka | ≤0.30% |
Xumaanta Keliya | ≤0.5% |
Wadarta wasakhda | ≤1.0% |
Biraha culus | ≤20pm |
daahirnimo | ≥99.0% |
Heerka Imtixaanka | Heerka Ganacsiga |
Isticmaalka | Dhexdhexaadiyaha Favipiravir (CAS: 259793-96-9) |
Xidhmada: Dhalo, Bac aluminium biil ah, Durbaan kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.
Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.
Shanghai Ruifu Chemical Co., Ltd. waa soo saaraha iyo soo saaraha 3,6-Dichloropyrazine-2-Carbonitrile (CAS: 356783-16-9) oo leh tayo sare leh.Waxaawaa dhexdhexaad caadi ahaan ku jira isku-dhafka 6-Fluoro-3-Hydroxypyrazine-2-Carboxamide ganacsi ahaan loogu magac daray Favipiravir (CAS: 259793-96-9).
Favipiravir (CAS: 259793-96-9) ee daaweynta caabuqyada fayraska hargabka.Favipiravir waa daawo ka hortag fayrus ah oo ballaaran oo ay nadiifisay Maamulaha Guud ee Dawooyinka Hindiya (DCGI) usbuucii hore "xaalad degdeg ah oo xaddidan" isticmaalka bukaannada Covid-19.Glenmark waxay ku iibin doontaa favipiravir guud ee magaca sumadda FabiFlu.Favipiravir waxaa asal ahaan soo saartay dabayaaqadii 1990-meeyadii shirkad ay markii dambe iibsatay shirkadda Japan ee Fujifilm taasoo qayb ka ahayd ka gudubka ganacsiga sawirka una gudubtay daryeelka caafimaadka.Ka dib markii lagu tijaabiyey noocyo kala duwan oo fayras ah, dawada waxaa laga ansixiyay Japan 2014 si loogu isticmaalo degdegga ah ee ka hortagga hargabka ama lagu daweeyo noocyada cusub ee hargabka.